Literature DB >> 23677540

[The association of unwanted drug effects and increased psychovegetative lability].

K Seikowski1, D Barth, A Majer, R Treudler.   

Abstract

OBJECTIVE: Based on a history of unwanted drug effects, patients had to undergo a series of exposure tests to identify alternative non-invasive drugs. In our study we examined if psychosomatic factors (in the sense of psychovegetative lability) occurred more frequently in patients with unwanted drug effects.
METHODS: For this purpose, 91 patients filled out a series of questionnaires for the assessment of mental factors. The questionnaires used were the BEB (a questionnaire for the assessment of psychosomatic complaints), the TICS questionnaire (Trierer questionnaire of chronic stress), the scale "critical life events" of LRF-LE and the anxiety questionnaire "STAI".
RESULTS: All scales which were used for the assessment of the psychosomatic complaint status (BEB) showed increased values. Chronic stress factors (TICS) and anxiety (STAI) did not play a role. Critical life events occurred more often.
CONCLUSION: The occurrence of unwanted drug effects is associated with psychosomatic complaints and acute critical life events. This enables the patient to get a complex understanding for the explanation of the complaints.

Entities:  

Mesh:

Year:  2013        PMID: 23677540     DOI: 10.1007/s00105-012-2498-5

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  9 in total

Review 1.  New drug therapies and their effect on the skin.

Authors:  Regina Treudler
Journal:  J Dtsch Dermatol Ges       Date:  2009-07       Impact factor: 5.584

2.  Flupirtine is a safe alternative drug in patients with hypersensitivity to NSAIDs.

Authors:  Regina Treudler; Katja Pohle; Jan Christoph Simon
Journal:  Eur J Clin Pharmacol       Date:  2011-03-09       Impact factor: 2.953

Review 3.  Psychosocial factors and chronic spontaneous urticaria: a systematic review.

Authors:  M Ben-Shoshan; I Blinderman; A Raz
Journal:  Allergy       Date:  2012-11-12       Impact factor: 13.146

4.  Prevalence and predictors of psychosocial morbidity in patients with chronic pruritic skin diseases.

Authors:  H van Os-Medendorp; P C M Eland-de Kok; M Grypdonck; C A F M Bruijnzeel-Koomen; W J G Ros
Journal:  J Eur Acad Dermatol Venereol       Date:  2006-08       Impact factor: 6.166

5.  Assessment of psychological aspects during systemic provocation tests in patients with pseudoallergic drug reactions.

Authors:  B Hermes; U R Hein; B M Henz
Journal:  J Eur Acad Dermatol Venereol       Date:  2006-08       Impact factor: 6.166

6.  Magical thinking in somatoform disorders: an exploratory study among patients with suspected allergies.

Authors:  C Hausteiner-Wiehle; F Sokollu
Journal:  Psychopathology       Date:  2011-06-09       Impact factor: 1.944

7.  Drug-induced angioedema.

Authors:  Marianne Lerch
Journal:  Chem Immunol Allergy       Date:  2012-05-03

8.  Patient-doctor interaction, psychobehavioural characteristics and mental disorders in patients with suspected allergies: do they predict "medically unexplained symptoms"?

Authors:  Constanze Hausteiner-Wiehle; Martine Grosber; Esther Bubel; Sylvienne Groben; Susanne Bornschein; Claas Lahmann; Florian Eyer; Bernadette Eberlein; Heidrun Behrendt; Bernd Löwe; Peter Henningsen; Dorothea Huber; Johannes Ring; Ulf Darsow
Journal:  Acta Derm Venereol       Date:  2011-10       Impact factor: 4.437

9.  High prevalence of mental disorders and emotional distress in patients with chronic spontaneous urticaria.

Authors:  Petra Staubach; Markus Dechene; Martin Metz; Markus Magerl; Frank Siebenhaar; Karsten Weller; Peter Zezula; Annegret Eckhardt-Henn; Marcus Maurer
Journal:  Acta Derm Venereol       Date:  2011-09       Impact factor: 4.437

  9 in total
  1 in total

Review 1.  [Adverse drug reactions in elderly people : First data from the Leipzig Research Center for Civilization Diseases (LIFE)].

Authors:  R Treudler; F Walther; P Ahnert; J-C Simon
Journal:  Hautarzt       Date:  2017-01       Impact factor: 0.751

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.